Skip navigation
  • Sciety Labs đź§Ş (Experimental)
  • Search
Sciety application utilities

Infectious Diseases (except HIV/AIDS)

  • Subscribe to feed (RSS)

Showing page 232 of 716 pages of list content

  • Daily Lactobacillus Probiotic versus Placebo in COVID-19-Exposed Household Contacts (PROTECT-EHC): A Randomized Clinical Trial

    This article's authors
    1. Paul E. Wischmeyer
    2. Helen Tang
    3. Yi Ren
    4. Lauren Bohannon
    5. Zeni E. Ramirez
    6. Tessa M. Andermann
    7. Julia A. Messina
    8. Julia A. Sung
    9. David Jensen
    10. Sin-Ho Jung
    11. Alexandra Artica
    12. Anne Britt
    13. Amy Bush
    14. Ernaya Johnson
    15. Meagan V. Lew
    16. Hilary M. Miller
    17. Claudia E. Pamanes
    18. Alessandro Racioppi
    19. Aaron T. Zhao
    20. Neeraj K. Surana
    21. Anthony D. Sung
    This article has 1 evaluations Latest evaluation on Jan 7, 2022 Published on Jan 5, 2022
  • Burden of SARS-CoV-2 and protection from symptomatic second infection in children

    This article's authors
    1. John Kubale
    2. Angel Balmaseda
    3. Aaron M Frutos
    4. Nery Sanchez
    5. Miguel Plazaola
    6. Sergio Ojeda
    7. Saira Saborio
    8. Roger Lopez
    9. Carlos Barilla
    10. Gerald Vasquez
    11. Hanny Moreira
    12. Anna Gajewski
    13. Lora Campredon
    14. Hannah Maier
    15. Mahboob Chowdhury
    16. Cristhiam Cerpas
    17. Eva Harris
    18. Guillermina Kuan
    19. Aubree Gordon
    This article has 1 evaluations Latest evaluation on Jan 7, 2022 Published on Jan 5, 2022
  • Discordant SARS-CoV-2 PCR and Rapid Antigen Test Results When Infectious: A December 2021 Occupational Case Series

    This article's authors
    1. Blythe Adamson
    2. Robby Sikka
    3. Anne L. Wyllie
    4. Prem Premsrirut
    This article has 1 evaluations Latest evaluation on Jan 7, 2022 Published on Jan 5, 2022
  • Safety and immunogenicity of anti-SARS CoV-2 conjugate vaccine SOBERANA 02 in a two-dose or three-dose heterologous scheme in adults: Phase IIb Clinical Trial

    This article's authors
    1. MarĂ­a Eugenia Toledo-Romani
    2. Mayra GarcĂ­a-Carmenate
    3. Leslyhana Verdecia-Sánchez
    4. Suzel Pérez-Rodríguez
    5. Meybis Rodriguez-González
    6. Carmen Valenzuela-Silva
    7. Beatriz Paredes-Moreno
    8. Belinda Sanchez-Ramirez
    9. Raúl González-Mugica
    10. Tays Hernández-Garcia
    11. Ivette Orosa-Vázquez
    12. Marianniz Díaz-Hernández
    13. María Teresa Pérez-Guevara
    14. Juliet Enriquez-Puertas
    15. Enrique Noa-Romero
    16. Ariel Palenzuela-Diaz
    17. Gerardo Baro-Roman
    18. Ivis Mendoza-Hernández
    19. Yaima Muñoz
    20. Yanet GĂłmez-Maceo
    21. Bertha Leysi Santos-Vega
    22. Sonsire Fernandez-Castillo
    23. Yanet Climent-Ruiz
    24. Laura RodrĂ­guez-Noda
    25. Darielys Santana-Mederos
    26. Yanelda GarcĂ­a-Vega
    27. Guang Wu-Chen
    28. Delaram Doroud
    29. Alireza Biglari
    30. Tammy Boggiano-Ayo
    31. Yury Valdés-Balbín
    32. Daniel GarcĂ­a-Rivera
    33. Dagmar GarcĂ­a-Rivera
    34. Vicente Vérez-Bencomo
    35. SOBERANA Research Group
    This article has 1 evaluations Latest evaluation on Jan 7, 2022 Published on Jan 5, 2022
  • Cell-mediated and humoral immune response to SARS-CoV-2 vaccination and booster dose in immunosuppressed patients

    This article's authors
    1. Lu M. Yang
    2. Cristina Costales
    3. Muthukumar Ramanathan
    4. Philip L. Bulterys
    5. Kanagavel Murugesan
    6. Joseph Schroers-Martin
    7. Ash A. Alizadeh
    8. Scott D. Boyd
    9. Janice M. Brown
    10. Kari C. Nadeau
    11. Sruti S. Nadimpalli
    12. Aileen X. Wang
    13. Stephan Busque
    14. Benjamin A. Pinsky
    15. Niaz Banaei
    This article has 1 evaluations Latest evaluation on Jan 7, 2022 Published on Jan 5, 2022
  • Performance evaluation of novel fluorescent-based lateral immune flow assay (LIFA) for rapid detection and quantitation of total anti-SARS-CoV-2 S-RBD binding antibodies in infected individuals

    This article's authors
    1. Farah M. Shurrab
    2. Nadin Younes
    3. Duaa W. Al-Sadeq
    4. Hamda Qotba
    5. Laith J. Abu-Raddad
    6. Gheyath K. Nasrallah
    This article has 1 evaluations Latest evaluation on Jan 7, 2022 Published on Jan 5, 2022
  • Comparison of infectious SARS-CoV-2 from the nasopharynx of vaccinated and unvaccinated individuals

    This article's authors
    1. Mario A. Peña-Hernández
    2. Jon Klein
    3. Amyn A. Malik
    4. Andreas Coppi
    5. Chaney Kalinich
    6. Chantal B. F. Vogels
    7. Julio Silva
    8. Yale SARS-CoV-2 Genomic Surveillance Initiative
    9. David R. Peaper
    10. Marie-Louise Landry
    11. Craig Wilen
    12. Nathan D. Grubaugh
    13. Wade Schulz
    14. Saad B. Omer
    15. Akiko Iwasaki
    This article has 1 evaluations Latest evaluation on Jan 6, 2022 Published on Jan 8, 2022
  • Vaccines Elicit Highly Cross-Reactive Cellular Immunity to the SARS-CoV-2 Omicron Variant

    This article's authors
    1. Jinyan Liu
    2. Abishek Chandrashekar
    3. Daniel Sellers
    4. Julia Barrett
    5. Michelle Lifton
    6. Katherine McMahan
    7. Michaela Sciacca
    8. Haley VanWyk
    9. Cindy Wu
    10. Jingyou Yu
    11. Ai-ris Y. Collier
    12. Dan H. Barouch
    This article has 1 evaluations Latest evaluation on Jan 6, 2022 Published on Jan 3, 2022
  • Mapping the antigenic diversification of SARS-CoV-2

    This article's authors
    1. Karlijn van der Straten
    2. Denise Guerra
    3. Marit J. van Gils
    4. Ilja Bontjer
    5. Tom G. Caniels
    6. Hugo D.G. van Willigen
    7. Elke Wynberg
    8. Meliawati Poniman
    9. Judith A. Burger
    10. Joey H. Bouhuijs
    11. Jacqueline van Rijswijk
    12. Wouter Olijhoek
    13. Marinus H. Liesdek
    14. A. H. Ayesha Lavell
    15. Brent Appelman
    16. Jonne J. Sikkens
    17. Marije K. Bomers
    18. Alvin X. Han
    19. Brooke E. Nichols
    20. Maria Prins
    21. Harry Vennema
    22. Chantal Reusken
    23. Menno D. de Jong
    24. Godelieve J. de Bree
    25. Colin A. Russell
    26. Dirk Eggink
    27. Rogier W. Sanders
    This article has 1 evaluations Latest evaluation on Jan 6, 2022 Published on Jun 6, 2022
  • Safety and immunogenicity of a heterologous boost with a recombinant vaccine, NVSI-06-07, in the inactivated vaccine recipients from UAE: a phase 2 randomised, double-blinded, controlled clinical trial

    This article's authors
    1. Nawal AlKaabi
    2. Yun Kai Yang
    3. Jing Zhang
    4. Ke Xu
    5. Yu Liang
    6. Yun Kang
    7. Ji Guo Su
    8. Tian Yang
    9. Salah Hussein
    10. Mohamed Saif ElDein
    11. Shuai Shao
    12. Sen Sen Yang
    13. Wenwen Lei
    14. Xue Jun Gao
    15. Zhiwei Jiang
    16. Hui Wang
    17. Meng Li
    18. Hanadi Mekki Mekki
    19. Walid Zaher
    20. Sally Mahmoud
    21. Xue Zhang
    22. Chang Qu
    23. Dan Ying Liu
    24. Jing Zhang
    25. Mengjie Yang
    26. Islam ElTantawy
    27. Peng Xiao
    28. Zhao Nian Wang
    29. Jin Liang Yin
    30. Xiao Yan Mao
    31. Jin Zhang
    32. Ning Liu
    33. Fu Jie Shen
    34. Liang Qu
    35. Yun Tao Zhang
    36. Xiao Ming Yang
    37. Guizhen Wu
    38. Qi Ming Li
    This article has 1 evaluations Latest evaluation on Jan 6, 2022 Published on Jan 4, 2022
Previous Next
Stay updated. Get involved.
Subscribe to Mailing List
  • Blog
  • About Sciety
  • Contact
  • Follow us on Twitter
  • Follow us on Facebook
© 2022 eLife Sciences Publications Ltd. Legal information